{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-025929","form_type":"8-K","ticker":"PPCB","cik":"0001517681","company_name":"Propanc Biopharma, Inc.","filed_at":"2024-07-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.342347+00:00","generated_at":"2026-05-31T23:45:38.668462+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Propanc Biopharma issues $33,750 convertible note with 35% discount for working capital","bullets":["Issued convertible promissory note to 104 LLC for gross proceeds of $30,375 after $2,500 legal fee deduction.","Note matures June 20, 2025, bears 10% interest (16% on default), convertible at 65% of lowest closing price over prior 10 days.","Company can prepay at premiums 110-125% of face within first 180 days; no prepayment right after.","Net proceeds used for general working capital; issued under Section 4(a)(2)/Rule 506(b) exemption.","Conversion shares subject to 4.99% beneficial ownership limitation and 500% reserve requirement."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-025929","json":"https://secwatch.observer/filing/0001493152-24-025929.json","markdown":"https://secwatch.observer/filing/0001493152-24-025929.md","text":"https://secwatch.observer/filing/0001493152-24-025929.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517681/000149315224025929/0001493152-24-025929-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517681/000149315224025929/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:45:38.668462+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}